What is Apixia?
Apixia operates at the intersection of advanced engineering and clinical dentistry, specializing in the development of high-precision digital dental imaging products. By providing a comprehensive suite of scanners, digital sensors, and specialized accessories, the company addresses the critical need for enhanced diagnostic accuracy in modern dental practices. Their market position is defined by a long-standing commitment to manufacturing excellence and a robust support infrastructure, which ensures that dental professionals can integrate sophisticated imaging technology into their workflows with minimal friction. As the industry shifts toward fully digitized patient records and high-resolution diagnostics, Apixia remains a key provider of the hardware necessary to facilitate this transition.
How much funding has Apixia raised?
Apixia has raised a total of $13K across 1 funding round:
Debt
$13K
Debt (2021): $13K with participation from PPP
Key Investors in Apixia
PPP
Public-Private Partnership
What's next for Apixia?
With the recent injection of $13K, Apixia is poised to transition from its established manufacturing base into a more aggressive phase of market expansion. The strategic focus will likely center on scaling production capabilities to meet rising global demand for digital sensors and refining their diagnostic software ecosystem. By leveraging this growth capital, the company aims to solidify its footprint in the competitive dental imaging landscape, potentially exploring new R&D initiatives that could further differentiate their product lineup from legacy competitors. The path forward involves balancing technical innovation with the operational rigor required to maintain their reputation for quality and reliable client support.
See full Apixia company page
